Under construction – not a live service
Sign in
Taking people in TaiwanNo phase

Tracking arterial stiffness and recovery in stroke patients after rehabilitation

Observes arterial stiffness changes after rehabilitation in people with subacute ischemic stroke.

Plain-language title generated from the registry record
Registry title: Pulse Wave Velocity and in Subacute Stroke Patients Following Rehabilitation

Key facts

Where
Taipei, TaiwanSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 80 years old?

Source: NCT06224517, who can take part

Where in Taiwan

  • Shin Kong Wu Ho Su Memorial HospitalTaipei, TaiwanTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Shin Kong Wu Ho-Su Memorial Hospital
Trial code
NCT06224517
Record updated
25 February 2025
Original description
Currently, the literature regarding the relationship between Pulse Wave Velocity (PWV) and functional recovery, particularly of upper limb function, in patients with subacute stroke is still limited. Therefore, the aim of the study is to evaluate the changes in baPWV after four weeks of intensive rehabilitation therapy, and the correlation between these changes and functional recovery.Read full original descriptionShow less

The Improvement in Pulse Wave Velocity and Its Correlation With Clinical Outcomes in Subacute Stroke Patients Following Rehabilitation

Currently, the literature regarding the relationship between Pulse Wave Velocity (PWV) and functional recovery, particularly of upper limb function, in patients with subacute stroke is still limited. Therefore, the aim of the study is to evaluate the changes in baPWV after four weeks of intensive rehabilitation therapy, and the correlation between these changes and functional recovery.

Inclusion: First-onset cerebral ischemic stroke within the previous 3 months, which is confirmed clinically by computed tomography scans or magnetic resonance imaging; Sufficient cognition to understand procedures and provide informed consent.

Exclusion: Concurrent neurological or neurodegenerative diseases (e.g. Parkinson's disease, multiple sclerosis, etc.); Hemorrhagic stroke, cerebellar or brainstem lesions which may affect autonomic or balance; Malignancy; Brain tumor; Limb deficiency or amputation.

ClinicalTrials.gov NCT06224517